November 18, 2019
Over the weekend this stock as increase a whooping 13 scents from .21 to a high of 33 cents so far. Keep your eyes on this one. Personally I think if it dips a fair amount from it’s high it’ll… Continue Reading…
November 15, 2019
“The current market boom, which started March 9, 2009, has enjoyed a whopping 468% gain for the S&P 500 through the first day of November, making this record-long bull run also the best-performing one since World War II, according to… Continue Reading…
November 15, 2019
“…Sienna Biopharmaceuticals, Inc. (SNNA) (the “Company”), a clinical-stage biopharmaceutical company, today announced that, on November 12, 2019, the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for continued listing on the Nasdaq Stock Market (“Nasdaq”), subject to certain conditions…” https://finance.yahoo.com/news/sienna-biopharmaceuticals-announces-successful-appeal-133000812.html… Continue Reading…
November 8, 2019
For those of you new to my website upon reading you’ll quickly find out I really like penny stocks. The experts say they’re dangerous. You can lose a lot of money really fast. On the flip side you can also… Continue Reading…
November 8, 2019
” The Dow and S&P 500 closed at fresh records Thursday… The Dow Jones Industrial Average DJIA, -0.18% rose 182.24 points, or 0.66%, to a record 27,674.80, while the S&P 500 index SPX, -0.15% gained 8.4 points, or 0.27%, to an all-time high of 3,085.18. The… Continue Reading…
November 7, 2019
“Uber shares hit a record low of $25.58 when the market opened Wednesday after hitting a previous low of $27.97 on Tuesday. Shares bounced back to nearly $27 per share, or 40% lower than its IPO price of $45…” https://www.cnn.com/2019/11/06/tech/uber-stock-lockup/index.html
November 6, 2019
Since before I started recommending stocks on my website I thought about this question. The answer to this question becomes more and more essential as my brand grows. I knew from the start there’s a good chance some actors in… Continue Reading…
November 6, 2019
“SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced that it filed a certificate of amendment to… Continue Reading…
November 5, 2019
Sellas Life Sciences hit 16 cents in a high today and it may go higher. Every reader who follows me is extremely fortunate. If you take my advice you have a very high chance of making money. I told everyone… Continue Reading…
October 28, 2019
“Oct. 28 has been the single best day of the year for stocks going back to 1950 with an average return of 0.54% on the S&P 500, according to Ryan Detrick, senior market strategist for LPL Financial. The S&P 500 hit… Continue Reading…
Recent Comments